HU Yangxi, LIU Yan, LI Mengzhu, DONG Xing, LI Ran, WANG Wenjuan, YE Jianping, LIU Hansong. Efficacy analysis of laparoscopic sleeve gastrectomy in treating patients with obese polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 49-52. DOI: 10.7619/jcmp.20234176
Citation: HU Yangxi, LIU Yan, LI Mengzhu, DONG Xing, LI Ran, WANG Wenjuan, YE Jianping, LIU Hansong. Efficacy analysis of laparoscopic sleeve gastrectomy in treating patients with obese polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 49-52. DOI: 10.7619/jcmp.20234176

Efficacy analysis of laparoscopic sleeve gastrectomy in treating patients with obese polycystic ovary syndrome

More Information
  • Received Date: December 20, 2023
  • Revised Date: February 26, 2024
  • Available Online: April 21, 2024
  • Objective 

    To observe the therapeutic effect of laparoscopic sleeve gastrectomy (LSG) in treating patients with obesity and polycystic ovary syndrome (PCOS).

    Methods 

    In this retrospective analysis, clinical materials of 60 patients with obesity and PCOS by LSG were analyzed, and postoperative improvements of PCOS symptoms were observed.

    Results 

    A total of 60 patients had a preoperative mean body mass index (BMI) of (39.4±5.4) kg/m2 and an average age of (26.3±6.1) years old, and all of them successfully completed LSG. After follow-up of 12 to 18 months, 50 cases (83.3%) had normalized menstrual cycles, with an average recovery time of (4.5 ±2.2) months after surgery, and 7 cases had natural pregnancy after surgery. Before surgery, ultrasound results in 35 patients indicated polycystic ovarian morphology (PCOM), and 29 cases (82.9%) regained normal ovarian status with an average recovery duration of (6.3±2.8) months. Complicated hyperandrogenemia was observed in 31 patients, and 29 cases (93.5%) exhibited normalization of testosterone levels within 18 months after surgery. At 18 months after surgery, the BMI was (26.47±4.70) kg/m2, the average weight loss was (32.4±7.4) %.

    Conclusion 

    LSG is a safe and effective treatment for obese PCOS.

  • [1]
    MAYER S B, EVANS W S, NESTLER J E. Polycystic ovary syndrome and insulin: our understanding in the past, present and future[J]. Womens Health, 2015, 11(2): 137-149.
    [2]
    RATH P, GAUTAM S. Homoeopathic management in a case of infertility with PCOS[J]. Homoeopathic Links, 2021, 34(2): 148-52. doi: 10.1055/s-0040-1712526
    [3]
    LIAO B Y, QIAO J, PANG Y L. Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology[J]. Front Endocrinol, 2021, 12: 667422. doi: 10.3389/fendo.2021.667422
    [4]
    CIBULA D, CÍFKOVÁ R, FANTA M, et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome[J]. Hum Reprod, 2000, 15(4): 785-789. doi: 10.1093/humrep/15.4.785
    [5]
    WILD R A, CARMINA E, DIAMANTI-KANDARAKIS E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society[J]. J Clin Endocrinol Metab, 2010, 95(5): 2038-2049. doi: 10.1210/jc.2009-2724
    [6]
    GAO L, ZHAO Y C, WU H Y, et al. Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury[J]. Circulation, 2023, 148(24): 1958-1973. doi: 10.1161/CIRCULATIONAHA.123.065827
    [7]
    HANNA F, WU P, HEALD A, et al. Diabetes detection in women with gestational diabetes and polycystic ovarian syndrome[J]. BMJ, 2023, 382: e071675.
    [8]
    FAUSER B C, TARLATZIS B C, REBAR R W, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J]. Fertil Steril, 2012, 97(1): 28-38, e25. doi: 10.1016/j.fertnstert.2011.09.024
    [9]
    BALEN A H, MORLEY L C, MISSO M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance[J]. Hum Reprod Update, 2016, 22(6): 687-708. doi: 10.1093/humupd/dmw025
    [10]
    BAHAWI Y O, RADWAN E M, KHOUJ M A, et al. Pregnancy rates in women with polycystic ovary syndrome (PCOS) using letrozole versus clomiphene citrate: a retrospective record review[J]. Cureus, 2023, 15(7): e42257.
    [11]
    SKUBLENY D, SWITZER N J, GILL R S, et al. The impact of bariatric surgery on polycystic ovary syndrome: a systematic review and meta-analysis[J]. Obes Surg, 2016, 26(1): 169-176. doi: 10.1007/s11695-015-1902-5
    [12]
    中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1): 2-6. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201810010.htm
    [13]
    AMINIAN A, CHANG J, BRETHAUER S A, et al. ASMBS updated position statement on bariatric surgery in class Ⅰ obesity (BMI 30~35 kg/m2)[J]. Surg Obes Relat Dis, 2018, 14(8): 1071-1087. doi: 10.1016/j.soard.2018.05.025
    [14]
    JENSEN M D, RYAN D H, APOVIAN C M, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society[J]. Circulation, 2014, 129(25 Suppl 2): S102-S138.
    [15]
    牛牧天, 孟化, 胡扬喜, 等. 对称三孔法腹腔镜袖状胃切除术治疗原发性高血压的疗效分析[J]. 腹腔镜外科杂志, 2022, 27(2): 90-95. https://www.cnki.com.cn/Article/CJFDTOTAL-FQJW202202003.htm
    [16]
    KENT J, DODSON W C, KUNSELMAN A, et al. Gestational weight gain in women with polycystic ovary syndrome: a controlled study[J]. J Clin Endocrinol Metab, 2018, 103(11): 4315-4323. doi: 10.1210/jc.2017-02764
    [17]
    MALIQUEO M, SUNDSTR? M POROMAA I, VANKY E, et al. Placental STAT3 signaling is activated in women with polycystic ovary syndrome[J]. Hum Reprod, 2015, 30(3): 692-700. doi: 10.1093/humrep/deu351
    [18]
    MILLS G, BADEGHIESH A, SUARTHANA E, et al. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies[J]. Hum Reprod, 2020, 35(7): 1666-1674. doi: 10.1093/humrep/deaa099
    [19]
    RISAL S, PEI Y, LU H J, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome[J]. Nat Med, 2019, 25(12): 1894-1904. doi: 10.1038/s41591-019-0666-1
    [20]
    木良善, 赵越, 乔杰. 肥胖与多囊卵巢综合征的关联性及潜在机制[J]. 中华生殖与避孕杂志, 2018, 38(4): 343-349.
    [21]
    JOHAM A E, NORMAN R J, STENER-VICTORIN E, et al. Polycystic ovary syndrome[J]. Lancet Diabetes Endocrinol, 2022, 10(9): 668-80. doi: 10.1016/S2213-8587(22)00163-2
    [22]
    LAITINEN J, TAPONEN S, MARTIKAINEN H, et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms[J]. Int J Obes Relat Metab Disord, 2003, 27(6): 710-715. doi: 10.1038/sj.ijo.0802301
    [23]
    KE Y Y, CHAI X Y. The life course health development model: a new approach to understanding human health[J]. J Zhejiang Univ Med Sci, 2021, 50(4): 411-419. doi: 10.3724/zdxbyxb-2021-0155
    [24]
    MITKA M. Bariatric surgery continues to show benefits for patients with diabetes[J]. JAMA, 2012, 307(18): 1901-1902. doi: 10.1001/jama.2012.3727
    [25]
    大中华减重与代谢手术数据库研究者团队. 大中华减重与代谢手术数据库2022年度报告[J]. 中国实用外科杂志, 2023, 43(5): 540-551. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK202305015.htm

Catalog

    Article views (125) PDF downloads (6) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return